Ryan Specialty Holdings, Inc. (NYSE:RYAN) Short Interest Down 19.5% in January

Ryan Specialty Holdings, Inc. (NYSE:RYAN - Get Free Report) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 4,500,000 shares, a drop of 19.5% from the December 31st total of 5,590,000 shares. Based on an average daily volume of 877,500 shares, the short-interest ratio is presently 5.1 days. Approximately 4.3% of the company's stock are short sold.

Ryan Specialty Stock Up 0.5 %

NYSE RYAN traded up $0.36 during midday trading on Wednesday, hitting $68.81. 774,262 shares of the company traded hands, compared to its average volume of 1,009,224. The company has a market cap of $18.02 billion, a PE ratio of 89.37, a price-to-earnings-growth ratio of 1.16 and a beta of 0.72. Ryan Specialty has a 52 week low of $42.34 and a 52 week high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company's 50-day simple moving average is $66.52 and its 200-day simple moving average is $66.72.

Insider Buying and Selling

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the business's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the sale, the executive vice president now owns 12,386 shares in the company, valued at approximately $884,236.54. The trade was a 54.42 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of the business's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the sale, the director now directly owns 2,697 shares in the company, valued at approximately $177,031.08. This trade represents a 92.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 338,296 shares of company stock worth $22,463,709. Corporate insiders own 11.10% of the company's stock.

Hedge Funds Weigh In On Ryan Specialty

A number of institutional investors have recently modified their holdings of the stock. Hollencrest Capital Management acquired a new position in Ryan Specialty in the 3rd quarter valued at about $25,000. Assetmark Inc. acquired a new position in Ryan Specialty during the 3rd quarter worth approximately $34,000. Principal Securities Inc. lifted its position in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after buying an additional 415 shares during the last quarter. Quarry LP increased its holdings in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after acquiring an additional 422 shares during the period. Finally, GAMMA Investing LLC raised its stake in shares of Ryan Specialty by 106.4% during the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock worth $83,000 after purchasing an additional 644 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company's stock.

Analysts Set New Price Targets

RYAN has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods dropped their price objective on Ryan Specialty from $79.00 to $77.00 and set an "outperform" rating on the stock in a research note on Friday, January 10th. Barclays upped their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a report on Thursday, November 21st. Wells Fargo & Company reduced their price target on shares of Ryan Specialty from $68.00 to $64.00 and set an "equal weight" rating on the stock in a research report on Tuesday, January 14th. The Goldman Sachs Group upped their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a research report on Wednesday, October 9th. Finally, Morgan Stanley initiated coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price target for the company. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $74.40.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.